Breakthrough sepsis in macrolide-resistant pneumococcal infection.
Jackson
M A
MA
Section of Infectious Disease, University of Missouri-Kansas City, USA.
Burry
V F
VF
Olson
L C
LC
Duthie
S E
SE
Kearns
G L
GL
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D017963:Azithromycin / Q000627:therapeutic use*; D016470:Bacteremia / Q000209:etiology*; D004352:Drug Resistance, Microbial; D005260:Female; D006801:Humans; D007223:Infant; D008586:Meningitis, Pneumococcal / Q000209:etiology*; D010033:Otitis Media / Q000150:complications / Q000188:drug therapy*; D011008:Pneumococcal Infections / Q000188:drug therapy* / Q000503:physiopathology; D013296:Streptococcus pneumoniae / Q000187:drug effects
D000900:Anti-Bacterial Agents; D017963:Azithromycin